ATA Inc. ("ATA" or the "Company") (Nasdaq:ATAI), a leading provider of advanced testing technologies and testing-related services in China, today announced that Ms. Shelly Jiang, the Company’s Interim CFO, has tendered her resignation effective April 1, 2017 to pursue other interests. Ms. Amy Tung, who has served in a variety of financial and operational positions within ATA over the past 11 years, including Acting CFO in 2010, will be appointed as Chief Financial Officer (“CFO”), as well as Financial and Principal Accounting Officer.

Mr. Kevin Ma, ATA's Chairman and Chief Executive Officer, said, “We would like to thank Shelly for her many contributions to ATA over the years and wish her all the best with her future endeavors. We are very pleased that Amy has agreed to lead our finance team as the Company’s new Chief Financial Officer, as she has served as an exceptional manager in different facets of our operations throughout her career at ATA. In every segment of ATA’s operations where Amy has worked, we have seen an immediate and lasting positive impact on our business. We believe Amy’s extensive financial and accounting background and intimate knowledge of our business will prove valuable as ATA works to increase its exposure in the capital markets.”

Ms. Tung has been with the Company since 2006, most recently serving as the Assistant to the CEO, a role in which she assisted the CEO in HR, strategic projects and board meeting activities. She previously served as ATA’s vice president/financial controller from 2006 to 2014, playing a crucial role in the Company’s finance department. This included serving as a conduit between shareholders and the Company since ATA’s initial public offering in January 2008.

Prior to her service with ATA, Ms. Tung has held various financial and accounting positions with Bayer Healthcare Limited in Hong Kong, BEA Systems (Hong Kong) Limited, Bureau Veritas Consumer Products Services (Hong Kong) Limited, Agilent Technologies Hong Kong Limited, and Compaq Computer Limited.

Ms. Tung received her master’s degree in financial engineering from Columbia University in 2002 and her MBA from the Chinese University of Hong Kong in 2001. She received a diploma in accounting in 1996 and a bachelor’s degree in computer science in 1994. She is a fellow member of the Association of Chartered Certified Accountants and the Hong Kong Institute of Certified Public Accountants.

Ms. Tung stated, “I am grateful for this opportunity to continue working with our team to build upon the Company’s successes in education and, more specifically, the testing services business. I believe this Company has the potential to achieve significant growth for many years to come, and I feel privileged to have been given a position where I can continue to serve ATA’s customers and shareholders.”

U.S. RoadshowManagement intends to visit with U.S. investors in June. For more information or to schedule a one-on-one meeting with management, please contact the Company’s investor relations firm The Equity Group.

About ATA Inc.ATA is a leading provider of advanced testing technologies in China. The Company offers comprehensive services for the creation and delivery of assessments based on its proprietary testing technologies and test delivery platform. ATA’s testing technologies are used for professional licensure and certification tests in various industries, including information technology services, banking, teaching, asset management, insurance, and accounting. As of December 31, 2016, ATA's test center network comprised 3,105 authorized test centers located throughout China. The Company believes that it has the largest test center network of any commercial testing service provider in China.

ATA has delivered more than 87.7 million billable tests since ATA started operations in 1999. For more information, please visit ATA’s website at www.atai.net.cn.

For more information on our company, please contact the following individuals:

At the Company          
ATA Inc.                        
Amy Tung, Chief Financial Officer
+86 10 6518 1122 x5518  
amytung@atai.net.cn             

Investor Relations 
The Equity Group Inc.
Carolyne Y. Sohn, Senior Associate
415-568-2255    
csohn@equityny.com                      

Katherine Yao, Senior Associate
+86 10 6587 6435
kyao@equityny.com

Adam Prior, Senior Vice President
212-836-9606
aprior@equityny.com     
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more ATAI Life Sciences NV Charts.
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more ATAI Life Sciences NV Charts.